Menopause-The Journal of the North American Menopause Society

Papers
(The TQCC of Menopause-The Journal of the North American Menopause Society is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Psychometric properties and validity of the Menopause Rating Scale in postmenopausal Portuguese women394
The effect of probiotic administration on the severity of menopausal symptoms and mental health of postmenopausal women: a triple-blind randomized controlled trial in the West of Iran105
Migraine and sleep quality: does the association change in midlife women?44
Reflecting on the enduring effects of childhood maltreatment22
Validation of the Menopause Transition Scale (MTS)20
Risk factors for delayed intrauterine device removal among menopausal women in rural China18
Urban-rural differences in epidemiology and risk factors of menopause syndrome in middle-aged Chinese women16
A call for health equity when addressing menopausal symptoms16
#Menopause: the menopause ontology project15
Health screening of middle-aged women: what factors impact longevity?15
Dietary patterns and prevalence of multimorbidity in women in southern Brazil14
Treating where it hurts: tailoring the genitourinary syndrome of menopause treatments13
Lessons Learned in Clinical Research Recruitment of Midlife Latinas During COVID-1912
Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis12
Vitamin D supplements and prevalent overactive bladder in women from midlife through older ages12
Superficial dyspareunia treatment with hyperstacking of erbium:yttrium-aluminum-garnet SMOOTH laser: a short-term, pilot study in breast cancer survivors11
The prevalence of osteoporosis in postmenopausal women in urban Tianjin, China and its related factors10
Low-serum anti-Müllerian hormone in middle-aged women associates with obesity markers10
Perimenopause meets life: observations from the Women Living Better Survey10
Association between vitamin D and calcium intakes, breast microcalcifications, breast tissue age-related lobular involution and breast density10
The association of vasomotor symptoms during the menopausal transition and cognition in later life10
Quality of life in Spanish postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study9
Risk factors for future osteoporosis in perimenopausal Japanese women9
The association between hormone therapy and the risk of lung cancer in postmenopausal women: a 16-year nationwide population-based study9
Menopause hormone therapy and urinary symptoms: a systematic review9
Examining long-term health impacts of multiparity8
Impact of the CBT-Meno protocol on menopause-specific beliefs, dysfunctional attitudes, and coping behaviors8
Pharmacological interactions and menopausal hormone therapy: a review8
Health care concerns in women at midlife: differences by race, ethnicity, and neighborhood socioeconomic status8
Cytological characteristics of premalignant cervical epithelial lesions in postmenopausal women based on endocrine indices and parakeratosis8
Risk of high depressive symptoms after the final menstrual period: the Study of Women’s Health Across the Nation (SWAN)8
Association of parity with body mass index and cardiometabolic risk in high-parous women8
Exercise training and vascular function in postmenopausal individuals: a systematic review and meta-analysis8
The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context7
Psychometric evaluation of the German Day-to-Day Impact of Vaginal Aging questionnaire using data from two intervention studies7
Network analysis of eating disorder symptoms in women in perimenopause and early postmenopause7
Letters to the editor7
Perception of higher frequency of daily hot flashes in 50-year-old women today: a study of trends over time during 48 years in the Population Study of Women in Gothenburg, Sweden7
Efficacy and safety of lemborexant in midlife women with insomnia disorder7
Screening for factors at midlife associated with reduced longevity in women7
Indian physicians' attitudes and practice regarding menopause and its management: a focus group discussion7
Does the addition of serum antimüllerian hormone concentrations to the Framingham Risk Score and Pooled Cohort Equations improve the prediction of cardiovascular disease?6
Menopause: The Journal of The North American Menopause Society Volume 29, 20226
Menopause hormone therapy and sarcodynapenia: the Canadian Longitudinal Study on Aging6
Impact of vitamin D supplementation on modulating heat-shock proteins in postmenopausal women: a randomized, double-blind, placebo-controlled study6
Nonhormone treatments for vasomotor symptoms6
Lipoprotein subfractions and subclinical vascular health in middle aged women: does menopause status matter?6
Isolated vitamin D supplementation improves the adipokine profile of postmenopausal women: a randomized clinical trial6
Climacteric status is associated with sexual dysfunction at the age of 46 years: a population-based study6
Postmenopausal giant ovarian tumor: a rare case report and literature review6
Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis5
Genitourinary syndrome of menopause—I know it when I see it—or do I?5
Should vitamin D supplements be prescribed routinely for midlife women?5
Uterine arcuate artery calcification as a potential marker of cardiovascular risk—a preliminary study5
Hysterectomy with or without ovarian conservation: similar associations with vascular health?5
Psychometric properties of a Persian version of the Vulvovaginal Symptoms Questionnaire for measuring vulvovaginal symptoms in postmenopausal women5
Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)5
Interactions between nutrient intake and comorbidities for quality of life in premenopausal and postmenopausal women5
2022 Annual Meeting of The North American Menopause Society October 12 – 15, 2022, Atlanta, GA5
Menopause for justice-involved women: consequences and care in prison systems5
Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update5
Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea–based retrospective cohort study5
Practice patterns and perspectives regarding treatment for symptoms of menopause: qualitative interviews with US health care providers5
Prasterone in the treatment of mild to moderate urge incontinence: an observational study5
0.051806211471558